NPS+ Rheumatoid Arthritis (EU5)
本報告依據法國、義大利、德國、西班牙、英國的150名風濕醫生的調查結果，提供類風濕性關節炎的領導品牌藥的醫生使用趨勢和各種見解彙整，支援客戶的忠誠度的NPS (淨推薦值) 指標的改善。
Few brands are earning high satisfaction scores in the European rheumatoid arthritis (RA) treatment market, but two long-time leaders continue to significantly outperform struggling rivals. Meanwhile, biosimilars are poised for huge market share gains if they can win over detractors.
Based on a survey of 150 rheumatologists, the report builds on the respected net promoter score (NPS), comparing brand loyalty for 11 major RA treatments and highlighting ways you can improve your brand's health-and boost market share-with easy-to-use KPIs.
We surveyed 150 rheumatologists from the EU5 (France, Italy, Germany, Spain, UK) , chosen from the largest community of validated physicians in the world. The same community that pharma market researchers trust for reliable, fast intelligence.
We conducted the survey between August 1st and 4th, 2016.
NPS+ Rheumatoid Arthritis (EU5) explores key issues affecting brand loyalty for drug manufacturers. You'll learn:
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)-are used to classify respondents into 3 categories:
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
NPS+ turns your Net Promoter Score into actionable information by answering key questions about brand loyalty.
Each NPS+ report examines doctors' relationships with the brands used to treat a major disease area-measuring brand loyalty and showing you how it affects your market share. NPS+ also examines “brand DNA”, revealing in doctors' own words what brands mean to them.
Instead of one simple metric, NPS+ gives you a detailed picture of brand health that highlights areas for improvement, and helps you see exactly what steps you need to take next.